{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:36:58Z","timestamp":1783042618056,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2022R1I1A1A01053069"],"award-info":[{"award-number":["NRF-2022R1I1A1A01053069"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["RS-2022-00166501"],"award-info":[{"award-number":["RS-2022-00166501"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbrc.2025.152000","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T01:59:21Z","timestamp":1747015161000},"page":"152000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["TAK-981 enhances antitumor activity in ELT3 uterine leiomyoma cells through the modulation of apoptosis, cell cycle arrest, and autophagy"],"prefix":"10.1016","volume":"770","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-5437","authenticated-orcid":false,"given":"Hyunju","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suho","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1918-0182","authenticated-orcid":false,"given":"Hosouk","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152000_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2025.152000_bib2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/s41379-020-0546-8","article-title":"Molecular and clinicopathologic characterization of intravenous leiomyomatosis","volume":"33","author":"Ordulu","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbrc.2025.152000_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1330807","article-title":"Gene variants polymorphisms and uterine leiomyoma: an updated review","volume":"15","author":"Upadhyay","year":"2024","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbrc.2025.152000_bib4","article-title":"Pedunculated subserosal leiomyoma with torsion, a rare cause of abdominal pain: a case report","volume":"102","author":"Chang","year":"2023","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.bbrc.2025.152000_bib5","first-page":"225","article-title":"The impact of uterine leiomyomas on reproductive outcomes","volume":"62","author":"Cook","year":"2010","journal-title":"Minerva Ginecol."},{"key":"10.1016\/j.bbrc.2025.152000_bib6","first-page":"320","article-title":"Transvaginal radiofrequency ablation: a therapeutic option for managing symptomatic uterine fibroids in women with reproductive desires","volume":"5","author":"Marin Martinez","year":"2024","journal-title":"F S Rep"},{"key":"10.1016\/j.bbrc.2025.152000_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/TCRM.S147318","article-title":"Uterine fibroids: an update on current and emerging medical treatment options","volume":"15","author":"Farris","year":"2019","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.bbrc.2025.152000_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5468\/ogs.2018.61.2.192","article-title":"Current medical treatment of uterine fibroids","volume":"61","author":"Sohn","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.bbrc.2025.152000_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1933719111432867","article-title":"Medical treatment of uterine leiomyoma","volume":"19","author":"Sabry","year":"2012","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.bbrc.2025.152000_bib10","article-title":"Currently available treatment modalities for uterine fibroids","volume":"60","author":"Micic","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bbrc.2025.152000_bib11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s43032-023-01418-2","article-title":"Recurrence of uterine fibroids after conservative surgery or radiological procedures: a narrative review","volume":"31","author":"Capezzuoli","year":"2024","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.bbrc.2025.152000_bib12","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","article-title":"Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer","volume":"64","author":"Langston","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152000_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba7791","article-title":"A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models","volume":"13","author":"Lightcap","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2025.152000_bib14","article-title":"The function of SUMOylation and its role in the development of cancer cells under stress conditions: a systematic review","volume":"2020","author":"Zhao","year":"2020","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.bbrc.2025.152000_bib15","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/1873-3468.14751","article-title":"SUMO in the regulation of DNA repair and transcription at nuclear pores","volume":"597","author":"Gasser","year":"2023","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2025.152000_bib16","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1074\/jbc.M513703200","article-title":"SUMO-1 controls the protein stability and the biological function of phosducin","volume":"281","author":"Klenk","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152000_bib17","first-page":"1081","article-title":"The post-translational modification, SUMOylation, and cancer","volume":"52","author":"Han","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2025.152000_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.tibs.2015.09.006","article-title":"SUMOylation-Mediated regulation of cell cycle progression and cancer","volume":"40","author":"Eifler","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2025.152000_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/nph.18748","article-title":"SUMOylation regulates low-temperature survival and oxidative DNA damage tolerance in botrytis cinerea","volume":"238","author":"Shao","year":"2023","journal-title":"New Phytol."},{"key":"10.1016\/j.bbrc.2025.152000_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.trecan.2023.04.010","article-title":"A new immuno-oncology target - SUMOylation","volume":"9","author":"Chen","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbrc.2025.152000_bib21","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/bloodadvances.2022007956","article-title":"TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently","volume":"7","author":"Kim","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.bbrc.2025.152000_bib22","first-page":"98","article-title":"SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia","volume":"109","author":"Gabellier","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2025.152000_bib23","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1136\/gutjnl-2021-324834","article-title":"Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model","volume":"71","author":"Kumar","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2025.152000_bib24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1158\/1535-7163.MCT-22-0762","article-title":"T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-Activating enzyme inhibitor, in chronic lymphocytic leukemia","volume":"22","author":"Lam","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bbrc.2025.152000_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215207","article-title":"Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer: retrospective single-center study","volume":"15","author":"Mereu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2025.152000_bib26","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8756","article-title":"2-D08 mediates notable anticancer effects through multiple cellular pathways in uterine leiomyosarcoma cells","volume":"52","author":"Joung","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2025.152000_bib27","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbrc.2025.152000_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13030312","article-title":"Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution","volume":"13","author":"Hong","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2025.152000_bib29","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/acs.chemrestox.9b00152","article-title":"N-Acetylcysteine: Antioxidant, aldehyde scavenger, and more","volume":"32","author":"Zhitkovich","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbrc.2025.152000_bib30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/hsz-2017-0131","article-title":"Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach","volume":"398","author":"Glorieux","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152000_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.bbrc.2025.152000_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152262","article-title":"Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators","volume":"11","author":"Gomez-Virgilio","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.152000_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2119\/2007-00101.YU","article-title":"Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas","volume":"14","author":"Yu","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152000_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2119\/molmed.2014.00053","article-title":"Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy","volume":"21","author":"Borahay","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152000_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.152000_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2025.152000_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102651","article-title":"PARP-1 and its associated nucleases in DNA damage response","volume":"81","author":"Wang","year":"2019","journal-title":"DNA Repair"},{"key":"10.1016\/j.bbrc.2025.152000_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081131","article-title":"Isoliquiritigenin suppresses E2-Induced uterine leiomyoma growth through the modulation of cell death program and the repression of ECM accumulation","volume":"11","author":"Lin","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2025.152000_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12620","article-title":"Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation","volume":"68","author":"Lin","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bbrc.2025.152000_bib40","first-page":"92","article-title":"The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer","volume":"21","author":"Yin","year":"2011","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:11:18Z","timestamp":1781701878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25007144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"alternative-id":["S0006291X25007144"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152000","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TAK-981 enhances antitumor activity in ELT3 uterine leiomyoma cells through the modulation of apoptosis, cell cycle arrest, and autophagy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152000"}}